High percentage of cancers potentially preventable

This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. This issue addresses the number of cancer cases and deaths in the United States that are attributable to modifiable risk factors. In addition, a new model accurately predicts treatment failure in patients with chronic myeloid leukemia, and blinatumomab is approved as a consolidation therapy for measurable residual disease‐negative B‐cell precursor acute lymphoblastic leukemia.